Friday - June 19, 2026
Goodwin Advises Incyte in Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Incyte's Hematology Portfolio into Bleeding Disorders
June 12, 2026
BOSTON, Massachusetts, June 12 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Incyte in Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Incyte's Hematology Portfolio into Bleeding Disorders

*

The Life Sciences team advised Incyte (Nasdaq: INCY) in its definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of St . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products